Valuation: Bayer AG

Market Cap 44.15B 49.69B 41.21B 37.56B 70.84B 4,777B 71.49B 499B 193B 2,442B 187B 183B 7,837B P/E 2026 *
20.4x
P/E 2027 * 14.7x
Enterprise Value 74.11B 83.41B 69.17B 63.04B 119B 8,018B 120B 837B 324B 4,099B 313B 306B 13,155B EV / Sales 2026 *
1.62x
EV / Sales 2027 * 1.51x
Free-Float
99.99%
Yield 2026 *
0.36%
Yield 2027 * 1.24%
1 day-3.28%
1 month+0.90%
3 months-6.31%
6 months+25.68%
Current year+37.99%
1 month 212.4
Extreme 212.4
220
Current year 140
Extreme 140
230.5
1 year 113.32
Extreme 113.32
230.5
3 years 78.97
Extreme 78.97
230.5
5 years 78.97
Extreme 78.97
241
10 years 78.97
Extreme 78.97
241
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 61 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-3.28%-.--% - - 49.69B
-0.61%-3.43%+36.07%+117.61% 1,019B
-1.02%-5.60%+35.72%+64.82% 617B
+1.11%-0.58%+12.36%+78.27% 464B
+0.34%-3.01%+61.79%+41.79% 356B
-0.95%-4.05%+20.54%+40.33% 333B
-1.46%-2.89%+10.57%+26.54% 267B
-1.35%-5.43%-6.17%+8.82% 244B
-1.04%-2.79%+35.30%+54.42% 218B
-1.87%-4.10%+28.44%+97.54% 179B
Average -1.01%-3.39%+26.07%+58.90% 410.8B
Weighted average by Cap. -0.63%-3.33%+29.07%+71.15%

Financials

2026 *2027 *
Net sales 45.83B 51.58B 42.78B 38.99B 73.53B 4,959B 74.22B 518B 201B 2,535B 194B 189B 8,136B 47.06B 52.97B 43.92B 40.04B 75.51B 5,092B 76.21B 532B 206B 2,603B 199B 195B 8,354B
Net income 2.14B 2.41B 2B 1.82B 3.43B 232B 3.47B 24.17B 9.37B 118B 9.04B 8.85B 380B 2.94B 3.31B 2.74B 2.5B 4.72B 318B 4.76B 33.21B 12.87B 163B 12.42B 12.15B 522B
Net Debt 29.96B 33.72B 27.96B 25.48B 48.06B 3,241B 48.51B 338B 131B 1,657B 127B 124B 5,318B 26.84B 30.21B 25.05B 22.83B 43.06B 2,904B 43.46B 303B 117B 1,484B 113B 111B 4,764B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
44.94EUR
Average target price
58.22EUR
Spread / Average Target
+29.56%

Quarterly revenue - Rate of surprise